6 results
8-K
EX-99.1
IVVD
Invivyd Inc
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am
identifier, age or date of birth, sex, weight, ethnicity, and race).
A statement “PEMGARDA use for the pre-exposure prophylaxis of COVID-19 under Emergency
8-K
EX-99.1
IVVD
Invivyd Inc
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
of birth, sex, weight, ethnicity, and race).
A statement “PEMGARDA use for the pre-exposure prophylaxis of COVID-19 under Emergency Use Authorization (EUA
8-K
EX-99.3
IVVD
Invivyd Inc
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
., patient identifier, age or date of birth, sex, weight, ethnicity, and race). Pre-exposure prophylaxis with PEMGARDA is not a substitute
DEF 14A
IVVD
Invivyd Inc
10 Apr 23
Definitive proxy
4:07pm
or Ethnicities
LGBTQ+
Did Not Disclose Race or Ethnicity
Did Not Disclose LGBTQ+ Status
Independence of the Board
As required under The Nasdaq Stock … diversity of race, ethnicity, gender, age, education, cultural background, skills, and other factors as it deems appropriate, given the current needs of our
PRE 14A
32zv195l 7qqe9l
31 Mar 23
Preliminary proxy
4:36pm
- Prev
- 1
- Next